BACKGROUND: Merkel cell carcinoma is a rare, aggressive neurocutaneous malignancy. This study investigated whether patients with Merkel cell carcinoma in the head and neck had poorer outcomes than patients with Merkel cell carcinoma located elsewhere. METHODS: A retrospective study was performed of patients with Merkel cell carcinoma treated at the Jewish General Hospital in Montréal, Canada, from 1993 to 2013. Associations between clinicopathological characteristics and disease-free and disease-specific survival rates were examined according to the Kaplan-Meier method. RESULTS: Twenty-seven patients were identified. Although basic clinicopathological characteristics and treatments were similar between head and neck and non-head and neck Merkel cell carcinoma groups, disease-free and disease-specific survival rates were significantly lower in the head and neck Merkel cell carcinoma group (log-rank test; p = 0.043 and p = 0.001, respectively). Mortality was mainly due to distant metastasis. CONCLUSION: Patients with head and neck Merkel cell carcinoma had poorer survival rates than patients with non-head and neck Merkel cell carcinoma in our study. The tendency to obtain close margins, a less predictable metastatic pattern, and/or intrinsic tumour factors related to the head and neck may explain this discrepancy.
BACKGROUND:Merkel cell carcinoma is a rare, aggressive neurocutaneous malignancy. This study investigated whether patients with Merkel cell carcinoma in the head and neck had poorer outcomes than patients with Merkel cell carcinoma located elsewhere. METHODS: A retrospective study was performed of patients with Merkel cell carcinoma treated at the Jewish General Hospital in Montréal, Canada, from 1993 to 2013. Associations between clinicopathological characteristics and disease-free and disease-specific survival rates were examined according to the Kaplan-Meier method. RESULTS: Twenty-seven patients were identified. Although basic clinicopathological characteristics and treatments were similar between head and neck and non-head and neck Merkel cell carcinoma groups, disease-free and disease-specific survival rates were significantly lower in the head and neck Merkel cell carcinoma group (log-rank test; p = 0.043 and p = 0.001, respectively). Mortality was mainly due to distant metastasis. CONCLUSION:Patients with head and neck Merkel cell carcinoma had poorer survival rates than patients with non-head and neck Merkel cell carcinoma in our study. The tendency to obtain close margins, a less predictable metastatic pattern, and/or intrinsic tumour factors related to the head and neck may explain this discrepancy.
Entities:
Keywords:
Head And Neck Neoplasms; Merkel Cell Carcinoma; Radiotherapy; Skin Neoplasms; Survival Analysis
Authors: Aaron J Arroyave; James M Lewis; Miles Landry; James M McLoughlin; Laura M Enomoto Journal: Ann Surg Oncol Date: 2021-12-01 Impact factor: 5.344
Authors: Adrienne B Shannon; Richard J Straker; Michael J Carr; James Sun; Karenia Landa; Kirsten Baecher; Kevin Lynch; Harrison G Bartels; Robyn Panchaud; Luke J Keele; Michael C Lowe; Craig L Slingluff; Mark J Jameson; Kenneth Y Tsai; Mark B Faries; Georgia M Beasley; Vernon K Sondak; Giorgos C Karakousis; Jonathan S Zager; John T Miura Journal: Ann Surg Oncol Date: 2022-07-22 Impact factor: 4.339
Authors: Seesha R Takagishi; Tessa E Marx; Christopher Lewis; Erica S Tarabadkar; Ilsa D Juhlin; Astrid Blom; Jayasri G Iyer; Jay J Liao; Yolanda D Tseng; Teresa Fu; Paul Nghiem; Upendra Parvathaneni Journal: Adv Radiat Oncol Date: 2016-10-20
Authors: Urs Dietmar Achim Müller-Richter; Anja Gesierich; Alexander Christian Kübler; Stefan Hartmann; Roman Camillus Brands Journal: Ann Surg Oncol Date: 2017-07-31 Impact factor: 5.344